These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32070484)

  • 61. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma.
    Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X
    Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MACC1-AS1 promotes hepatocellular carcinoma cell invasion and proliferation by regulating PAX8.
    Tong H; Liu X; Li T; Qiu W; Peng C; Shen B; Zhu Z
    Aging (Albany NY); 2020 Jan; 12(1):70-79. PubMed ID: 31915309
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
    Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
    Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.
    Yang J; Li C; Li H; E C
    J Cell Physiol; 2019 Aug; 234(10):18415-18422. PubMed ID: 30908634
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
    Gao Y; Zhu H; Mao Q
    J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
    [TBL] [Abstract][Full Text] [Related]  

  • 71. LncRNA
    Zhang H; Luo C; Zhang G
    DNA Cell Biol; 2019 Aug; 38(8):857-864. PubMed ID: 31237446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC.
    Jia X; Wang Y; Yang Y; Fu Y; Liu Y
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139458
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells.
    Liu W; Huai R; Zhang Y; Rao S; Xiong L; Ding R; Mao C; Zhao W; Hao T; Huang Q; Guo Z
    Genes Genomics; 2019 Aug; 41(8):951-959. PubMed ID: 31066006
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
    Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
    Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network.
    Nong S; Chen X; Wang Z; Xu G; Wei W; Peng B; Zhou L; Wei L; Zhao J; Wei Q; Deng Y; Meng L
    Biomed Res Int; 2021; 2021():9972011. PubMed ID: 34692847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
    Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
    Zhang HH; Li AH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel Long Noncoding RNAs,
    Qin Y; Tu X; Huang M; Ma C; Huang Q; Huang Q; Shu H; Ou C
    DNA Cell Biol; 2023 Aug; 42(8):488-497. PubMed ID: 37527208
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
    Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
    Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.